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A B S T R A C T
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is the cause of severe reproductive and re-
spiratory disease in swine worldwide. In Denmark, both PRRSV-1 and PRRSV-2 are circulating and approxi-
mately 35% of pig herds are seropositive for PRRSV.
In November 2010, a pig herd in the Northern part of Denmark experienced an infection with PRRSV-2 with
clinical signs that were much more severe than normally reported from current Danish PRRSV-2 aﬀected herds.
Due to the clinical observations of reproductive failure in sows and high mortality in piglets, it was speculated
that a new, more pathogenic or vaccine evading PRRSV strain had emerged in Denmark. The overall aim of the
present study was to perform a genetic and biological characterization of the virus isolated from the diseased
herd. Complete genome sequencing of isolates from this herd revealed that although the case strain had some
unique genetic features including a deduced 3 amino acid deletion, it was in overall very similar to the other
PRRS-2 viruses circulating in Denmark. In an experimental trial in growing pigs, no overt clinical signs or
pathology were observed following intranasal inoculation with the new virus isolate. Virus shedding, acute
phase protein responses and serological responses were comparable to those seen after experimental challenge
with a Danish PRRSV-2 reference strain isolated in 1997. Vaccination with a commercial modiﬁed live PRRSV-2
vaccine had a clear reducing eﬀect on virus shedding, magnitude, and duration of viremia and viral load in the
lungs. Overall, the results indicate that the severe disease observed in the ﬁeld was contributed by additional
factors in combination with the PRRS virus infection.
1. Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
belongs to the order Nidovirales (Cavanagh, 1997) and has recently
been reclassiﬁed to the Porartevirus genus in the Arteriviridae family
(https://talk.ictvonline.org/ictv-reports/ictv_online_report). PRRSV is
the cause of severe respiratory and reproductive disease in swine
worldwide (Botner et al., 1994; Han et al., 2006; Karniychuk et al.,
2010; Tian et al., 2007). PRRSV is an enveloped single-stranded posi-
tive-sense RNA virus with a genome size of 15.0–15.5 kb containing a
5′-end cap and a 3′-end polyadenine tail (Meulenberg et al., 1998). The
genome encodes at least 10 open reading frames (ORFs) (Firth et al.,
2011; Johnson et al., 2011; Meulenberg et al., 1993; Wu et al., 2001).
Due to the high genetic and serologic diversity between PRRSV isolates
(Allende et al., 1999; Wensvoort et al., 1992) the virus was divided into
two major genotypes; Type 1 and Type 2. Both genotypes are circu-
lating globally (Shi et al., 2010). In Denmark, PRRSV-1 was detected for
the ﬁrst time in 1992, and PRRSV-2 was introduced in 1996 in con-
nection with an extensive vaccination program (Botner et al., 1997;
Madsen et al., 1998). Approximately 35% of the Danish herds are ser-
opositive for antibodies against PRRSV (Kristensen et al., 2014; Lopes
Antunes et al., 2015).
Occasionally, highly virulent PRRSV strains evolve, with signiﬁcant
impact on animal welfare (Balka et al., 2015; Han et al., 2006;
http://dx.doi.org/10.1016/j.vetmic.2017.10.001
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Karniychuk et al., 2010; Sinn et al., 2016; Tian et al., 2007) and asso-
ciated with huge economic losses (Holtkamp et al., 2013). In 2006,
China experienced the emergence of a highly pathogenic strain of
PRRSV, which was similar to other Chinese PRRSV-2 strains in ORF5,
but exhibited unique diﬀerences in other ORFs (An et al., 2010; Tian
et al., 2007). The PRRSV epidemic in China aﬀected more than 2 mil-
lion pigs with about 400,000 fatal cases which also included grown pigs
(Tian et al., 2007) and subsequently spreading to other Southeast Asian
countries (An et al., 2011; Feng et al., 2008). In general, PRRSV-2 in
Europe are similar and share a high level of identity to the VR2332
vaccine strain, but more diverse and pathogenic strains have been re-
ported in recent years (Balka et al., 2015; Jackova et al., 2013). Oc-
currence of highly pathogenic and diverse PRRSV strains has also been
observed in Eastern Europe (Karniychuk et al., 2010; Morgan et al.,
2013) and North America (Han et al., 2006) emphasizing the im-
portance of monitoring the diversity of circulating PRRSV strains
globally both with respect to the sensitivity and speciﬁcity of diagnostic
tests as well as eﬃcacy of available vaccines.
In November 2010, a severe case of PRRS with high mortality rate in
piglets occurred in a farrow-to-ﬁnisher herd in the Northern part of
Denmark. By real-time RT-PCR, PRRSV-2 was detected in lung tissue
samples from 10-day-old piglets submitted to the Danish National
Veterinary Institute for routine diagnostics. The samples were negative
for swine inﬂuenza virus, porcine circovirus type 2 (PCV2) and
Mycoplasma hyopneumoniae. Vaccination with the Ingelvac® PRRS
modiﬁed live vaccine (MLV) was initiated in the herd. Within the ﬁrst 6
weeks after the initial observation of disease, pre-wean mortality in-
creased up to 50% among the live-born piglets. After 6 weeks, pre-
weaning mortality was back to normal however between week 6 and
week 14 up to 75% of the fetuses were mummiﬁed. In February 2011
(12 weeks after the initial infection was recognized in piglets), pleura
and lung tissues from dead fetuses and stillborn piglets were found
positive for PRRSV-2 by real-time RT-PCR. The samples were negative
for porcine parvovirus, PCV2 and Leptospira spp. Approximately 15
weeks following the initial infection, the number of live born piglets
had returned to normal (33 weaned piglets per sow per year). Total
losses of piglets until weaning for the 15-week period were around
30%. The average loss in the nursery was 9.3% until 18 weeks after the
initial infection. Nineteen weeks after the initial infection, post weaning
mortality was back to normal (2.2%).
Since the clinical impact in the infected herd appeared to be more
severe than usually reported for Danish PRRSV-2 aﬀected herds, it was
speculated that a new, more pathogenic PRRSV strain had evolved in
Denmark similar to the strains that had previously evolved in
Minnesota (USA), China and Eastern Europe (Han et al., 2006;
Karniychuk et al., 2010; Morgan et al., 2013; Tian et al., 2007). Thus,
the overall aim of the present study was to make a genetic and biolo-
gical characterization of the virus isolated from the case herd by full-
genome sequence analysis of the isolate and by comparing the patho-
genicity of the virus with an older Danish PRRSV-2 isolate by experi-
mental infection of young pigs. The protective eﬀect of a modiﬁed live
virus (MLV) PRRSV-2 vaccine against this recent Danish PRRSV-2 iso-
late was also assessed.
2. Materials and methods
2.1. Case samples
All samples were collected from the case herd between November
2010 and March 2011. In November 2010, lung samples from nine 10-
day-old piglets were obtained. In February 2011, lungs from 7 mum-
miﬁed fetuses, and 13 lungs and 11 pleura samples from stillborn
piglets were collected and ﬁnally, in March 2011, lungs and livers from
3 stillborn piglets and lungs and/or hearts and livers from 11 mum-
miﬁed fetuses were collected. From the samples submitted in November
2010, one virus, designated DK-2010-10-13-1 (KF183946), was isolated
from a 2nd passage on in-house culture stock of Marc-145 cells a de-
rivate of African green monkey kidney cells using general cell culture
procedures (Kim et al., 1993).
2.2. Screening of case samples by real-time RT-PCR
RNA was extracted from lung tissue, serum and nasal swabs as
previously described (Stadejek et al., 2017). Total RNA from cell culture
supernatants for full genome sequencing was puriﬁed using QIAamp
Viral RNA Mini Kit (QIAGEN). PRRSV positive samples and negative
controls were included in each 24-sample batch of RNA puriﬁcations.
RNA extracted from lung tissue and pleura from case animals and fe-
tuses were screened for PRRSV using a modiﬁcation of a previously
published primer-probe energy transfer (PriProET) assay (Balka et al.,
2009). The ﬂuorophore on the probe was changed to ATTO663 and the
reaction was run in RNA UltraSense ™ One-Step Quantitative RT-PCR
System (Invitrogen).
2.3. Cycle sequencing and next generation sequencing
PCR ampliﬁcation of ORF5 and ORF7 was performed as previously
described (Kvisgaard et al., 2013a). PCR ampliﬁcation of partial-NSP2
was carried out using the primers described by Zhou et al. (Zhou et al.,
2009) and the same PCR cycle conditions as for the ORF5 and ORF7
ampliﬁcations. PCR products were sequenced by cycle sequencing using
the Sanger method with the PCR primers as sequencing primers (Sanger
et al., 1977). The sequencing was conducted by LGC Genomics GmbH
(Berlin, Germany). Full-genome cDNA synthesis with Superscript III
First-Strand Synthesis System (Invitrogen) and long range PCR ampli-
ﬁcations were performed as described by Kvisgaard et al. (2013b). The
complete genomes of DK-2010-10-13-1 (KF183946) and DK-2011-
88005-A8-PI (KF183947) were obtained using next generation se-
quencing methods described elsewhere (Kvisgaard et al., 2013a,
2013b).
2.4. Sequence data analysis
Data analysis of sequences obtained from cycle sequencing was
carried out using the commercial software CLC Main Workbench v.
6.6.2 (CLC BIO, Arhus, Denmark). Contigs of ORF5 and ORF7 were
produced from assembling the raw data obtained for cycle sequencing
against the reference sequence VR2332 (PRU87392). The complete
genomes of DK-2010-10-13-1(KF183946) and DK-2011-88005-A8-Pl
(KF183947) were obtained by the mapping of reads using the Burrows-
Wheeler aligner (BWA) (Kvisgaard et al., 2013b). Amino acid (aa) se-
quences were predicted from the nucleotide (nt) sequences using CLC
Main Workbench v. 6.6.2. Nt and aa sequences were aligned using
MUSCLE (MUltiple Sequence Comparison by Log- Expectation).
2.5. Inoculum and virus propagation in cell culture
The two virus isolates used in the experimental infection study were
propagated in Marc-145 cells (in house cell culture stock) using stan-
dard procedures (Kim et al., 1993). For both virus isolates used in the
experimental infection study, a fresh second passage of cell culture
supernatant was used as inoculation material. The virus titers of the
isolates were determined using an immunoperoxidase monolayer assay
(IPMA) as described previously (Botner et al., 1994; Markussen and
Have, 1992). SDOW17 PRRSV monoclonal antibody (RTI, LLC) was
used as primary antibody and horseradish peroxidase (HRP) conjugated
rabbit anti-mouse IgG (DAKO) as the secondary antibody. The DK-
1997–19407B (KC862576) isolate, an older Danish PRRS-2 virus
(Nielsen et al., 2002), had a titer of 5.4 log10 TCID50/ml. The DK-
2010-10-13-1 isolate had a titer of 5.9 log10 TCID50/ml. One ml of cell
culture supernatant was diluted in cell culture medium to a total vo-
lume of 4 ml and administered intra-nasally to each pig with 2 ml per
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nostril.
2.6. Experimental set-up
Twenty-eight 4-week-old pigs (Landrace X Yorkshire X Duroc cross-
breeds) of both sexes were purchased from a commercial pig herd
seropositive for Actinobacillus pleuropneumoniae (AP) serotypes 6 and
12, but declared free from a range of important swine pathogens in-
cluding Mycoplasma hyopneumoniae, PRRSV and AP serotypes 1, 2, 3, 4,
5, 7, 8, 9 and 10 according to the Danish Speciﬁc Pathogen Free (SPF)
system. The pigs were blindly divided into one control group with four
pigs (group 1) and three experimental groups (groups 2–4) each with
eight pigs. The randomization did not follow any speciﬁc rule. The
diﬀerent groups were housed in separate sections of the BSL3 animal
isolation facilities at the National Veterinary Institute, Lindholm. After
an acclimatization period of 5 days, the pigs in group 4 (pig nos. 21–28)
were vaccinated intramuscularly (i.m) with 2 ml of the Ingelvac® PRRS
MLV vaccine (Boehringer Ingelheim Animal Health; Ingelheim,
Germany). Four weeks later, at day post infection (DPI) 0, the pigs in
group 1 (pig nos. 1–4) were sham- inoculated intranasally (i.n.) with
MEM. The pigs in group 2 (pig nos. 5–12) and group 3 (pig nos. 13–20)
were inoculated i.n. with the DK-1997–19407 B and the case DK-2010-
10-13-1 isolate, respectively. The vaccinated pigs in group 4 (pig nos.
21–28) were challenged with the DK-2010-10-13-1 case isolate. The
pigs in groups 1 and 4 were euthanized 29 DPI and the other two groups
were euthanized 30 DPI. Euthanasia was performed by intravenous
injection of pentobarbiturate (50 mg/kg) followed by exsanguination
by cutting arteria axillaris. All procedures of animal handling and ex-
perimentation were approved by the Danish Animal Experiments
Inspectorate (2012-15-2934-00681).
2.7. Clinical examination
Individual pigs were subjected to daily clinical examination and the
rectal temperatures were measured. To avoid inﬂuence of handling on
the body temperature recordings, these were usually carried out while
pigs were eating. In order to obtain a semi-quantitative measure for
comparison of clinical disease between the four groups, all pigs were
scored using the clinical scoring (CS) system developed for swine fever
infections (Mittelholzer et al., 2000) adapted for PRRSV experiments by
focusing on PRRS typical clinical signs in growing pigs. All pigs were
evaluated clinically twice daily and all deviations from normal re-
corded.
2.8. Blood and nasal swab sampling
Blood samples were collected from all pigs on DPIs−28, 0, 3, 7, 10,
14, 21, 28, and 29/30 (days of euthanasia) for clinical, virological,
hematological and immunological examinations. Samples obtained on
DPI −28 and 0 were collected prior to vaccination and inoculation,
respectively. Non-stabilized whole-blood samples were collected in 5 or
10 ml vacutainers (Venoject; Terumo Europe) from the anterior vena
cava and left on ice to coagulate for 15 min. Serum was separated by
centrifugation at 2600×g for 10 min at 4 °C and stored at − 80 °C for
subsequent analysis. EDTA-stabilized blood samples were collected in 5
or 10 ml haematology vacutainers (Venoject; Terumo Europe) from the
anterior vena cava. The freshly collected EDTA-stabilized samples were
used for total white blood cell (WBC) counts and ﬂow cytometry ana-
lysis. Nasal swabs were collected on the same days as blood samples
except on−28 and 29/30 DPI. The swabs (FLOQSwabs™, COPAN) were
placed in 1 ml PBS (pH 7.5) and stored at− 80 °C until further analysis.
2.9. Tissue sampling
The experimentally inoculated pigs were necropsied for character-
ization of type, distribution, and severity of gross lesions and the
following tissue samples were collected: nasal mucous membrane,
tonsil, trachea (middle part), tracheobronchial lymph node, liver and
spleen. Two identical samples were taken from the lungs from the right
apical- and diaphragmatic lobes, the intermediate lobe and from lesions
if present. One of each lung sample was ﬁxed in 10% neutral buﬀered
formalin, dehydrated, embedded in paraﬃn wax and cut in 3–5 μm
thick sections. For histopathological examination the sections were
mounted on conventional glass slides, stained with hematoxylin and
eosin, and evaluated blinded and systematically. The other tissue
samples were stored at − 80 °C for later analysis by real-time RT-PCR.
Selected lungs samples were prepared and propagated in Marc-145 cell
culture as described in Section 2.7.
2.10. Total WBC counts
Total WBC counts were carried out on freshly collected EDTA-sta-
bilized blood samples using a semi-automated animal blood cell counter
(Vet abcTM, ABX, Montpellier, France). All samples were counted
twice, and the mean value was calculated.
2.11. Flow cytometry analyses
Phenotyping of leukocytes in peripheral blood was carried out by
ﬂow cytometry, using single as well as triple labeling methods to deﬁne
diﬀerent sub-populations. Single-color analysis was applied to diﬀer-
entiate leukocyte populations and for B cell detection, as previously
described (Nielsen et al., 2003). Phenotyping of peripheral blood T cell
subpopulations was performed by triple-color ﬂow cytometry using
CD3/CD8/CD4 labelling, as previously described (Nielsen et al., 2003).
Selection of gates was as described elsewhere (Summerﬁeld et al.,
2001). This permitted the identiﬁcation of the T cell subpopulations as
CD3+CD4+CD8− naïve Th cells, CD3+CD4+CD8+ as memory/acti-
vated Th cells, CD3+CD4−CD8+ as Tc cells, CD3+CD4−CD8low//− as
γδ T cells. NK cells were deﬁned as CD3−CD4−CD8+ cells.
2.12. Quantiﬁcation of viral load in experimentally infected pigs
For quantitative real-time RT-PCR, the previously published
“Kleiboeker mod-1” primers and probe targeting PRRSV-2 ORF7 3′UTR
(Wernike et al., 2012) were used. All samples were tested in duplicates.
Quantiﬁcations of viral load in the experimental samples were
performed against standard curves matching each of the inoculation
virus isolates and imported into each real-time RT-PCR run with ad-
justment according to a PRRSV RNA calibrator sample included in tri-
plicate.
Standard curves for quantiﬁcation of DK-2010-10-13-1 virus were
obtained using a ﬁve-fold dilution series of 5.9 log10 TCID50/ml of DK-
2010-10-13-1 inoculum virus isolate spiked 1:100 into PRRSV negative
swine serum and nasal swab material, respectively. RNA was extracted
from each spiked dilution and tested in triplicate by real-time RT-PCR
in at least two independent PCR experiments. The serum and nasal
swab standard curves had a PCR eﬃciency of 97% (R2 = 0.99,
slope =−3.398) and 91% (R2 = 0.99; slope =−3.547) respectively,
and their range of quantiﬁcation covered 7 and 6 log5 dilution steps
corresponding to concentrations 0.5 − 8.0 × 103 and 0.52–8.1 × 103
TCID50/ml equivalents, respectively. Similarly, standard curves for
quantiﬁcation of DK-1997–19407 B virus in serum and nasal swabs
were produced by spiking of 5.4 log10 TCID50/ml DK-1997–19407B
inoculum virus isolate in PRRSV negative serum and nasal swab ma-
terial. The PCR eﬃciencies were 98% (R2 = 0.98; slope =−3.374)
and 93% (R2 = 0.99; slope =−3.909), respectively, and both covered
6 log5 dilution steps corresponding to concentrations 0.5–1.4 × 103
and 0.14–2.3 × 103 TCID50/ml equivalents, respectively.
Similarly, standard curves for quantiﬁcation of DK-2010-10-13-1
and DK-1997–19407 B in lung tissue were obtained by spiking of the
corresponding virus isolates diluted 1:200 in Buﬀer RLT with 1% β-
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mercaptoethanol and used for preparation of 5-fold dilution series in
PRRSV negative lung tissue homogenate The DK-2010-10-13-1 lung
tissue standard curve had an eﬃciency of 90% (R2 = 0.99;
slope =−3.589) and covered 8 log5 dilution steps corresponding to a
concentration of 0.07–4.0 × 103 TCID50/ml equivalents. The DK-
1997–19407B lung tissue standard curve had an eﬃciency of 92%
(R2 = 0.99; slope =−3.534) and covered 8 log5 dilution steps cor-
responding to a concentration of 0.02–1.58 × 103 TCID50/ml equiva-
lents.
2.13. Serology
Antibodies in sera from experimentally infected pigs were analyzed
using a PRRSV immunoperoxidase monolayer assay (IPMA) (Sorensen
et al., 1997) and a blocking enzyme-linked immunosorbent assay
(ELISA) (Sorensen et al., 1998). For IPMA, the serum was initially di-
luted 1:50 and then tested using a ﬁvefold dilution series (1:50-1:6250).
The results were expressed as the highest dilution generating a positive
signal (titer). For ELISA, sera were diluted 1:2 and the results expressed
as blocking percentage (OD%). A sample was considered positive if the
OD was below 44%.
2.14. Acute phase proteins
Plasma levels of haptoglobin and C-reactive protein (CRP) were
determined by a sandwich ELISA as previously described (Heegaard
et al., 2009; Stadejek et al., 2017).
2.15. Statistics
Unpaired t-tests with 95% conﬁdence interval and two-sided
ANOVA tests were performed for the comparisons of responses between
groups using GraphPad Prism version 5.00 for Windows, GraphPad
Software, San Diego California USA, www.graphpad.com.
3. Results
3.1. Case samples were positive for PRRSV-2 and shared high level of
genetic identity
All nine lungs from 10 day-old piglets collected during the initial
outbreak in November 2010 were found positive for PRRSV-2 by real-
time RT-PCR and also the lungs from two fetuses and three stillborn
piglets and pleura from one stillborn piglet collected in February 2011
tested positive for PRRSV-2. Similarly, lungs from one stillborn piglet
and nine mummiﬁed fetuses that were collected in the farm in March
2011 were positive for PRRSV-2, however, the Ct value was rather high
(Ct> 39).
The ORF5 and ORF7 sequences from case PRRSV-2 positive samples
obtained in November 2010 were more than 99.2% identical between
animals. The pairwise nt sequence identity for ORF5 and ORF7 of these
viruses to Ingelvac PRRS MLV vaccine were 96.9-97.4% and 98.4-
98.7%, respectively. Alignment of the deduced aa sequence of ORF5
revealed up to 10 aa diﬀerences in the glycoprotein 5 (GP5) of the case
viruses compared to the vaccine strain (Supplementary Fig. 1). Since
some of the aa positions in GP5 (e.g. G3, Y24, and N35) were identical
to variants present in the HP-PRRSV strains from China (Supplementary
Fig. 1), a partial fragment of 772 bp of the coding region of NSP2
covering the region containing the Chinese HP-PRRSV typical deletions
were sequenced and compared to three Chinese HP-PRRSV strains. This
analysis revealed that the case viruses did not harbor the typical 1 plus
29 aa deletions of the HP-PRRSV strains (Tian et al., 2007), but instead
harbored a 3 aa deletion 28 aa downstream of the 1 plus 29 aa deletion
(Supplementary Fig. 2). BLASTp searches of GenBank did not reveal any
published sequences harboring this 3 aa deletion in nsp2 of PRRSV-2
but in addition to this deletion, several aa diﬀerences were present. The
pairwise partial nsp2 aa sequence similarities to the vaccine strain was
89.75–91.39%.
Comparison of ORF5, ORF7 and partial NSP2 sequences obtained
from viruses from the initial infection in November 2010 to the se-
quences obtained from mummiﬁed fetuses and stillborn piglets sampled
approximately 12 weeks later (February 2011) conﬁrmed that it was
the same virus strain that had persisted in the herd. The pairwise nt
sequence identities were 99.3–99.8%, 99.7–100%, and 99.3–100%, for
ORF5, ORF7, and partial NSP2 respectively. The aa alignments further
conﬁrmed the similarity of these viruses with 98.5–100%, 100%, and
98.8–100% pairwise aa identities in GP5, N, and partial nsp2 respec-
tively.
Complete PRRSV genome sequences were obtained from viral RNA
extracted from lung tissue and pleura from pigs submitted in November
2010 (DK-2010-10-13-1) and February 2011 (DK-2011-88005-A8-Pl),
respectively. The complete genomes were 15,402 nt long (excluding the
poly(A)-tail) and the pairwise nt identity between the two genomes was
99.7%. The identity to the vaccine strain was 97.8–97.9%. Apart from
the 3 aa deletion in nsp2 no further deletions were found. Thus, only
limited genetic drifts occurred during the outbreak
3.2. The genomic sequences of DK-2010-10-13-1 and DK-1997–19407B
were very similar
The genetic identity between the two full genomes DK-2010-10-13-
1 and DK-1997–19407B used as inoculum in the experimental infection
study was 97.6%. In detail, they shared 96.7%, 98.7%, and 93.9%
pairwise nt identity in ORF5, ORF7, and partial NSP2 respectively. In
comparison, the full genome of DK-1997–19407B shared 99.4% iden-
tity to the vaccine strain with 98.6%, 100%, and 99% similarity in
ORF5, ORF7, and partial NSP2 respectively. Thus, the strain was highly
similar to the typical PRRSV-2 strains isolated in Europe during the last
15 years.
3.3. The challenge strains induced limited changes in clinical signs and body
temperature and induced limited pathological changes in the lungs
Generally, all pigs remained healthy throughout the experimental
period, and only few deviations from normal health were observed
(data not shown). On DPI 18, Pig no. 7 (DK-1997-19407B) was slightly
lethargic, had increased respiratory rate when eating and increased
body temperature (40.2 °C). Short (13 days) episodes of semi-liquid
feces were observed occasionally in all groups. Slightly increased body
temperatures of short durations were observed on two occasions for
group 4 (Fig. 1A) and could be related to restraint of pigs or to the
episodes with semi-liquid feces. There were no statistical diﬀerences
between the groups.
At necropsy, no lesions were seen in the control pigs and only minor
lesions were observed in the inoculated pigs. Thus, in pigs inoculated
with DK-1997-19407B, focal lobular consolidation in the cranial lung
lobe (n = 1) and slightly enlarged tracheobronchial lymph nodes were
seen (n = 4). Pig no. 7 was pale and had chronic adhesive pleuritis and
pericarditis, and the spleens of three pigs were mottled with slightly
depleted margins. In pigs inoculated with DK-2010-10-13-1, ﬁndings
were mildly enlarged tracheobronchial lymph nodes (n = 2) and mot-
tled spleens with slightly depleted margins (n = 2). Among the vacci-
nated pigs, small areas of condensation were seen in the cranial lung
lobes (n = 2). In the dorsal lung lobes ecchymotic hemorrhages (n = 1)
and areas of collapsed lung tissue (atelectasis) (n = 1) were present.
Two pigs had slightly depleted margins of the spleen.
Histopathological examinations revealed only minor lesions. All
pigs had mild to moderate hyperplasia of the bronchus-associated
lymphoid tissue and areas of slightly thickened alveolar septa, which
was regarded as a normal pulmonary response to environmental factors
(Hansen et al., 2010). One of the control pigs (no. 3) had mild focal
non-suppurative bronchopneumonia. Among the pigs inoculated with
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DK-1997-19407B, one (no. 9) had mild multifocal non-suppurative in-
terstitial pneumonia and another (no. 7) had an abscess, and chronic
suppurative bronchopneumonia and pleuritis. In pigs inoculated with
DK-2010-10-13-1, mild multifocal non-suppurative interstitial pneu-
monia was seen (nos. 13, 14, 18). Findings among the vaccinated pigs
were mild multifocal non-suppurative interstitial pneumonia (no. 21)
and focal peracute suppurative bronchopneumonia (no. 24). Thus,
overall the challenge strains induced weak clinical signs and limited
pathology.
3.4. Challenge induced typical changes in WBC
The numbers of WBC counts developed almost in parallel for pigs
inoculated with DK-1997–19407B and DK-2010-10-13-1 and for the
control and vaccinated pigs, respectively (Fig. 1B). The decreased levels
of WBC seen for pigs inoculated with DK-1997–19407B or DK-2010-10-
13-1 at DPI 3 and 7, most pronounced for pigs inoculated with DK-
1997-19407B, represented signiﬁcant reductions of absolute lympho-
cyte counts compared to the control and vaccinated pigs (p < 0.05).
This was characterized by signiﬁcantly reduced levels of B cells in pigs
inoculated with DK-1997–19407B or DK-2010-10-13-1, together with
decreased numbers of CD8+ cells (T cells and NK cells) in pigs in-
oculated with DK-1997-19407B, only (data not shown). At DPI 14, WBC
values for pigs inoculated with DK-1997–19407B or DK-2010-10-13-1
had returned to DPI 0 levels. The WBC counts of control and vaccinated
pigs gradually decreased throughout the experimental period. Gen-
erally, the percentages of individual lymphocyte subpopulations did not
change during the period (data not shown).
3.5. Both challenge strains induced viremia and nasal shedding of PRRSV,
but vaccination had a clear eﬀect on the level of virus
To compare the viral load of the pigs in the diﬀerent challenge
groups, the levels of PRRS virus were quantiﬁed by real-time RT-PCR in
all pigs inoculated with PRRSV (DK-1997-19407B, DK-2010-10-13-1,
and vaccinated group). The viremia peaked around DPI 7 in all in-
oculated pigs (Fig. 2A), but the viral load was signiﬁcantly lower in the
vaccinated pigs compared to the DK-1997–19407B group at DPIs 3, 7,
10, and 14 and between the vaccinated group and the DK-2010-10-13-1
group at DPIs 3–21 (Fig. 2A). In pigs inoculated with DK-1997–19407B
or DK-2010-10-13-1, the mean viral load reached approximately 3 log10
TCID50/ml equivalents and PRRSV remained detectable until the end
of the experiment at DPI 28. The mean viral load was higher in the
group of pigs inoculated with DK-2010-10-13-1 than with DK-
1997–19407B at DPI 10 and 14 although the diﬀerences were not
statistically signiﬁcant. Low levels of PRRSV were detected at DPI 0 in
serum from 4 out of 8 pigs in the vaccinated pigs and these results were
reproduced from a second RNA extraction from the same serum sam-
ples. None of the other pigs were positive for PRRSV by real-time RT-
PCR at DPI 0.
To investigate the shedding of virus in the diﬀerent groups, the level
of virus was quantiﬁed in nasal swab samples. Virus shedding was de-
tected in all pigs in the inoculated non-vaccinated groups from DPI 3
and peaked with approximately one log10 TCID50/ml equivalent at DPI
7 (Fig. 2B). In the group of pigs inoculated with DK-1997-19407B, virus
was detected until DPI 7 in three pigs, until DPI 10 in four pigs, and
until DPI 14 in one pig. The DK-2010-10-13-1 inoculated pigs were
positive for virus in nasal swab samples until DPI 10 for six pigs, one pig
was positive until DPI 14 and one pig had detectable levels of virus at
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 Fig. 1. Variations over time in body temperatures (A) and absolute num-
bers of total WBC (B) of uninfected control pigs (N = 4), DK-1997–19407B
(N = 8) and DK-2010-10-13-1 (N = 8) and vaccinated (N = 8) pigs fol-
lowing challenged with two diﬀerent strains of PRRSV. DPI: day post in-
fection. There were no statistical diﬀerences in body temperature between
the groups. * And # indicate statistical diﬀerences (p < 0.05) between
the WBC counts of the DK-1997–19407B and DK-2010-10-13-1 group
compared to the control and vaccinated pigs, respectively.
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DPI 21. In the vaccinated pigs, only two out of the eight pigs showed
detectable levels of virus in nasal swabs at DPI 10. Thus, the vaccinated
pigs had decreased virus shedding compared to the two non-vaccinated
groups. There was a signiﬁcant diﬀerences in virus shedding between
the vaccinated group and the DK-1997–19407B and at DPI 3 and 7 and
between the vaccinated group and the DK-2010-10-13-1 group at PID 3,
7 and 10 (Fig. 2B).
Virus load in lung tissue samples were quantiﬁed by real-time RT-
PCR and the TCID50/ml equivalents calculated. All lung samples from
all control animals were negative by real-time RT-PCR (Fig. 3). In pigs
inoculated with DK-1997–19407B or DK-2010-10-13-1, PRRSV was
detected in all tested lung samples (i.e. from right apical (4) and the
intermediate (8) and diaphragmatic (9) lobes), except for lung samples
number 8 and 9 from pig number 8 inoculated with DK-1997–19407B
(Fig. 3). For the vaccinated animals, all pigs had at least one positive
lung sample, but in total, ﬁve of the individual lung samples were ne-
gative. The highest virus load was detected in right apical- and the
intermediate lobes and in general the amount of virus was highest in
unvaccinated animals challenged with DK-2010-10-13-1 and lowest in
the vaccinated pigs challenged with this virus (Fig. 3). No signiﬁcant
diﬀerences in virus load in the lungs were detected.
Four lung samples from pigs inoculated with DK-1997-19407B, four
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Fig. 2. Mean viral load (log10 TCID50 equivalents/ml) (± SD) after challenge
in serum (A) and nasal swabs (B) quantiﬁed by real-time RT-PCR. DPI: Day post
infection. N = 4 for the control group and N = 8 for the remaining three groups.
*. **, *** Indicate signiﬁcant diﬀerence between the control group and the DK-
1997–19407B group at 0.001, 0.001 and 0.05 level, respectively. Similarly, ¤, ¤
¤, ¤¤¤ indicate signiﬁcant diﬀerences between the control group and the DK-
2010-10-13-1 group. #, ##, ### indicate signiﬁcant diﬀerences between DK-
2010-10-13-1 and DK-1997–19407B and the vaccinated group. #^ indicate a
signiﬁcant diﬀerence (p < 0.05) between the control group and the vaccinated
group. No legends indicate that there were no signiﬁcant diﬀerences.
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Fig. 3. Mean viral load (log10 TCID50 equivalents) (± SD) at necropsy
(DPI 29/30) in the right apical (4), intermediate (8) and the diaphragmatic
lung lobes (9). Lung samples from control animals were PRRS virus ne-
gative (data not shown). No signiﬁcant diﬀerences were seen between the
groups.
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samples from pigs inoculated with DK-2010-10-13-1, and two samples
from vaccinated pigs had log10 TCID50/ml equivalents above 2.40 and
were tested for infectious PRRS virus by inoculation in Marc-145 cells
to investigate if the PRRSV virus detected in the lungs by RT-PCR re-
presented live virus. As controls, two PRRSV PCR negative lung samples
from control animals were tested. Nine out of the 11 samples from in-
fected pigs were positive by culturing whereas the remaining two
samples and the samples from the control animals were negative. Thus,
the lungs indeed contained infectious virus at necropsy.
3.6. Challenge of pigs with PRRSV led to seroconversion and induction of
acute phase proteins
All animals were negative for PRRSV antibodies by ELISA at day
−28 and only vaccinated animals had antibodies at DPI 0 (Fig. 4A). All
pigs inoculated with DK-1997–19407B or DK-2010-10-13-1 ser-
oconverted at DPI 7 followed by a steady increase in level of antibodies
that remained high until the end of the study at DPI 28. A similar de-
velopment in IPMA titers was observed (Fig. 4B) however, the pigs
inoculated with DK-1997–19407B or DK-2010-10-13-1 seroconverted
at DPI 14 in IPMA compared to DPI 7 in ELISA.
The acute phase responses were included as an objective indicator
of the severity of infection. Results from measurements of the acute
phase proteins C – Reactive Protein (CRP), and haptoglobin are shown
in Fig. 5A and B, respectively. The control pigs and PRRSV inoculated
pigs showed a clear CRP response following inoculations at DPI 0,
peaking on DPI 7 and with a second peak at DPI 21 (only for pigs
inoculated with DK-1997-19407B). Similarly, haptoglobin peaked at
around DPI 10 for pigs inoculated with DK-1997–19407B or DK-2010-
10-13-1. The CRP and haptoglobin responses of the pigs in the vacci-
nated group were similar to the responses of the pigs in the sham in-
oculated control group and showed some random increases and de-
creases throughout the observation period.
There was a signiﬁcant diﬀerence in haptoglobin concentration
between control pigs and pigs inoculated with DK-1997–19407B when
using an unpaired t-test with 95% conﬁdence interval (p = 0.04)
(Fig. 5B). No other signiﬁcant diﬀerences were observed between the
groups.
4. Discussion
The aim of the present study was to perform a genetic and biological
characterization of PRRSV isolated from a herd with severe re-
productive and respiratory clinical signs and to compare the virulence
of the virus to an early Danish PRRSV-2 isolate under controlled ex-
perimental conditions. Although the case strain DK-2010-10-13-1 had
some unique genetic features it was overall very similar to con-
temporary and earlier Danish PRRSV-2 viruses belonging to clade 5.1
(Kvisgaard et al., 2013a; Shi et al., 2010). Furthermore, the virus in-
duced no overt clinical signs or pathology in pigs following intranasal
inoculation.
Terms such as “high and low pathogenicity”, “high and low viru-
lence” and “hot strains” are often used interchangeably to allocate
PRRSV isolates into pathotypes, but eﬀorts to link speciﬁc genetic
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Fig. 4. Test of serum samples for PRRSV antibodies. (A) PRRSV an-
tibody level (means ± SD) in serum determined by blocking ELISA. A
sample was positive when the blocking percentage was below 44%
(cut oﬀ shown by the black horizontal line). (B) Antibody titers
(means ± SD) measured by immunoperoxidase monolayer assay
(IPMA). The serum samples were tested in ﬁve ﬁve-fold dilutions
(1:50–1:6250) and the results expressed as the highest dilution giving
a positive signal. DPI: day post infection.
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motifs to diﬀerent biological and immunological features have so far
been unsuccessful. Thus, until now no clearly deﬁned molecular marker
of virulence has been established for PRRSV (Opriessnig et al., 2002;
Wu et al., 2009). The 1 + 29 aa deletions seen in nsp2 of the so-called
high pathogenic PRRSV strains in China were initially believed to be a
virulence marker, however, experimental infections performed with
chimeric infectious clones and the ﬁnding of a low pathogenic ﬁeld
virus also harboring the same deletions have subsequently shown that
the 1 + 29 aa discontinuous deletion alone was not directly related to
virulence (Li et al., 2010; Zhou et al., 2009). The nt sequences revealed
that the DK-2010-10-13-1 isolate used as inoculum was 97.4% and
94.8% identical to the Ingelvac® PRRS MLV vaccine strain in ORF5 and
partial NSP2, respectively. The pairwise nt identity between the se-
quences obtained from the viruses from the initial infection and those
obtained approximately 12 weeks later were 99.3–99.8%, 99.7–100%,
and 99.3–100% identical in ORF5, ORF7, and partial NSP2, respec-
tively. Taken together, these results documented that the same virus
was isolated 3 months apart and that this strain was less than 5% dif-
ferent from the vaccine strain. The strain belonged to the same cluster
as PRRSV-2 normally found in Denmark (clade 5.1) (Kvisgaard et al.,
2013a) which are all related to the Ingelvac® PRRS MLV vaccine strain.
The level of identity between the two strains used for inoculation was
overall 97.6%, approximately 96% in ORF5 and 94% in NSP2. The DK-
2010-10-13-1 strain had a deletion of three aa in nsp2 not previously
described for any PRRSV-2 strains (Kvisgaard et al., 2013a). This un-
ique 3 aa deletion has subsequently been shown also to be present in
PRRSV-2 samples collected from 6 out of 14 other Danish pig herds
(accession no. KF311033-57). Five of these samples were collected in
2010 and 2012 and one was collected in 2003. It is not known if these
herds experienced severe clinical signs so the use of this 3 aa deletion as
a predictor/marker of virulence is not supported by the available data.
Results from previous studies support the concept that the magni-
tude and duration of viremia is the best indicator of the virulence of a
given PRRSV strain, however, a direct quantitative relationship be-
tween virulence and viral load has not been established (Haynes et al.,
1997; Johnson et al., 2004; Weesendorp et al., 2013). In the present
study, the level of virus in serum was higher from DPI 3 and onwards in
pigs infected with the DK-2010-10-13-1 virus in comparison to the
older Danish DK-1997–19407B virus and the virus load in lung tissue
samples also tended to be higher. Furthermore, the viremia was shorter
and less pronounced than described for other strains of PRRSV causing
signiﬁcant clinical disease and mortality in experimental trials
(Johnson et al., 2004; Weesendorp et al., 2013). On the contrary, a
more pronounced reduction of B- and CD8+ cells were seen in animals
inoculated with the older Danish isolate DK-1997-19407B, indicating
that this infection may compromise immune functions more severely
than the DK-2010-10-13-1 virus. Thus, it is unlikely that the diﬀerences
in duration and magnitude of viremia between the case strain and an
older Danish PRRSV-2 virus can explain the severe clinical signs and
mortalities seen in the herd from which this virus was isolated. With
respect to pathology, no obvious diﬀerences were seen between the four
groups and in general the changes were mild. This is in accordance with
previous ﬁndings after experimental infection with PRRSV-2 (Halbur
et al., 1995).
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Fig. 5. Levels of acute phase proteins. Serum concentration of C-
creative protein (CRP) (A) and haptoglobin (B) in the four experi-
mental groups expressed as group means (± SEM). DPI: day post
infection.
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Neither overt clinical signs nor mortalities related to the PRRSV
infection were seen in the present experimental study albeit the pigs
were indeed infected as documented by the signiﬁcant acute phase
protein responses, the viremia, and the development of antibodies
against PRRSV. There are many possible explanations for diﬀerences in
clinical impact in the ﬁeld and in experimental set up’s. Indeed, others
have previously failed to provoke severe clinical disease in growing pigs
(Halbur et al., 1996) probably because the clinical impact are inﬂu-
enced by other factors such as management, and co-infections with
swine inﬂuenza virus, PCV2, Mycoplasma and other bacterial infections
(Harms et al., 2001; Schmitt et al., 2001). Indeed, the temporary de-
crease of absolute lymphocyte and B cell numbers in both unvaccinated
groups of pigs indicated a state of immunosuppression following in-
fection, which may prime the animals for secondary infections in the
ﬁeld.
The inﬂuence of other factors on the impact of PRRSV infection is
also supported by observations from the ﬁeld where a large variation in
severity of outbreaks between herds are observed. The age of the pigs
may also inﬂuence the outcome of the experimental study since the pigs
in the present study was older than the pigs showing the most severe
clinical signs in the herd. Furthermore, the applied model using non-
pregnant pigs does not evaluate the impact on reproductive parameters.
The impact of PRRSV on pigs may also depend on the breed and sex of
the animals, however, it is doubtful that these parameters were re-
sponsible for the diﬀerent outcome of the experimental trial and the
ﬁeld infection since pigs of both sexes were included in the experiment
and the breed of the pigs used in the experimental study were Landrace
X Yorkshire X Duroc cross-breeds which are similar to most Danish
herds.
Vaccination of the pigs with a modiﬁed live PRRSV vaccine had a
clear reducing eﬀect on virus load in serum and lungs, viral secretion
and acute phase responses despite the fact that the diﬀerence between
the vaccine isolate and the case virus ranged from 3 to 6% in some
genes.
In conclusion, the PRRS virus isolated from a herd experiencing
severe clinical signs and signiﬁcant mortalities, failed to induce overt
clinical signs or pathology in a respiratory pig model. Full genome se-
quencing of the isolate revealed that the isolate was very similar to
other Danish PRRSV-2 isolates. Combined, these data indicated that the
severe disease seen in the ﬁeld was caused by other factors than the
PRRS virus. This conﬁrmed that clinical impact in the herds is an un-
reliable indicator of virulence. Early identiﬁcation of emerging PRRSV
isolates with increased virulence is indeed very important for the fur-
ther control of PRRSV, but it is too resource demanding to perform
experimental infections each time such events are encountered in the
ﬁeld. Thus, research aimed at identifying molecular virulence makers of
PRRSV are highly needed for fast clariﬁcation when suspicion of hot
strains are reported from the ﬁeld.
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